Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Ardelyx Inc ARDX

Healthcare Biotechnology
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease... see more

Current News (NDAQ:ARDX)

Ardelyx Reports Preliminary 2025 Revenue and Provides 2026 Strategic Outlook

GlobeNewswire 12 days ago

Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week

GlobeNewswire November 7, 2025

Ardelyx to Participate at the Jefferies Global Healthcare Conference in London

GlobeNewswire November 5, 2025

Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference

GlobeNewswire November 4, 2025

Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire October 30, 2025

Ardelyx Presents Data that Continues to Support the Benefits of IBSRELA® (tenapanor) at the American College of Gastroenterology's 2025 Annual Meeting

GlobeNewswire October 28, 2025

Ardelyx Announces Four Abstracts Accepted for Poster Presentations at the American Society of Nephrology's Kidney Week

GlobeNewswire October 21, 2025

Ardelyx to Report Third Quarter 2025 Financial Results on October 30, 2025

GlobeNewswire October 13, 2025

Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer

GlobeNewswire October 13, 2025
View More News ››

Opinion & Analysis (NDAQ:ARDX)

Ardelyx's Shares Soar 65% as Tenapanor Phase 3 Study Hits the Mark

Streetwise Reports September 4, 2019

Why the election is not as relevant to drug stocks as you might believe

The Life Sciences Report November 4, 2016
View More Opinion ››

Bullboard Posts (NDAQ:ARDX)

ARDX.....it took awhile but check it out

Volume & Price action..........$3.59
Iseneschal - March 3, 2023

ARDX.... Steady as she goes ; )

$3.10...... To the moon ?
Iseneschal - January 13, 2023

ARDX..... Been a constant staedy climb since June

Fiiling the gap..... Should be some news soon. Here is the last NR..... FDA Grants Appeal for Ardelyx's XPHOZAH ‚ ®...
Iseneschal - January 11, 2023

ARDX....did anyone other than me BTFD ?

Now over $3 Not a seller.... Cheers !
Iseneschal - January 11, 2023

ARDX ..... early a.m runner now in PB mode

Pick your spot..... I'm going to BTFD...sub $2.75  Cheers 
Iseneschal - January 9, 2023

ARDX .... N>H>O>D

Right before the close
Iseneschal - December 22, 2022
View more Bullboard ››

North Peak Resources Ltd.

North Peak Resources Ltd.

North Peak Resources Ltd. operates as a gold exploration and development company. The company’s flagship project is the ...
View More »

Podcasts